Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
iohexol (647mg/ml) Injection
Therapeutic Category
Nephrology
Dosage Form
Injection
Packaging Type
Vial
Packaging
mono
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Iohexol 647 mg/ml Injection is a non-ionic, water-soluble contrast agent used in diagnostic imaging procedures such as CT scans, angiography, and other radiological examinations. It enhances the visibility of internal structures for accurate diagnosis.
Iohexol works by improving contrast in imaging by absorbing X-rays, allowing clear differentiation of tissues, blood vessels, and organs. Its low osmolality ensures better patient tolerance and reduced side effects.
This injection is widely used in hospitals, diagnostic centers, and radiology departments due to its safety profile and effectiveness in imaging procedures. It plays a crucial role in modern diagnostic practices.
Common side effects may include a feeling of warmth, nausea, vomiting, headache, or mild pain at the injection site. Some patients may experience dizziness or a metallic taste. Rarely, severe allergic reactions, kidney function impairment, or cardiovascular complications may occur.
Iohexol 647 mg/ml Injection is indicated as a radiographic contrast agent for diagnostic imaging procedures such as CT scans, angiography, urography, and other X-ray examinations. It enhances the visibility of blood vessels, organs, and tissues to aid in accurate diagnosis.
This medication should be administered under strict medical supervision in a clinical setting. Adequate hydration is recommended before and after administration to reduce the risk of kidney damage. Inform your doctor about any history of allergy to contrast media, kidney disease, or thyroid disorders.
Store in a cool, dry place below 25°C. Protect from light. Do not freeze. Keep in original packaging and out of reach of children. Use as directed.
Composition : Brivaracetam (10mg) Injection
Composition : Biapenem (300mg) Injection
Composition : Cefepime (250mg)
Composition : Cefotaxime (1000mg) Injection
Composition : Cefoperazone (500mg) + Sulbactam (500mg)
Composition : Cefoperazone (2gm) + Sulbactam (1gm)
Composition : Cytarabine (1000mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Iohail 647 Injection, containing Iohexol 647mg/ml, has strong demand in diagnostic imaging and hospital radiology segments, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on contrast media and hospital supply portfolios.
Medical distributors and agencies can benefit from the consistent hospital demand for radiographic contrast agents used in CT scans, angiography, urography, and other diagnostic imaging procedures. Iohail 647 Injection helps strengthen a comprehensive diagnostic and hospital care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Iohail 647 Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady institutional demand, reliable product availability, professional support, and access to a trusted diagnostic imaging product range when partnering for Iohail 647 Injection distribution.
Medical distributors, stockists, and wholesalers interested in Iohail 647 Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.